NF1 rs1057518904: Understanding This Rare Genetic Variant
The rs1057518904 variant is a rare genetic alteration located within the NF1 gene. It is classified as pathogenic and is associated with neurofibromatosis type 1, a condition that increases the risk of developing various benign and malignant tumors.
What each genotype means
Typical NF1 risk profile
This genotype represents the common, non-variant sequence at this position in the NF1 gene. It is not associated with the pathogenic changes linked to neurofibromatosis type 1 or related tumor-predisposing syndromes.
This is the most common genotype found in the general population.
Potential NF1 variant carrier
This genotype indicates the presence of one copy of the G allele, which is classified as pathogenic in clinical databases. Carriers of this variant may have an increased risk for neurofibromatosis type 1 and associated tumor-predisposing conditions, though clinical expression can vary significantly between individuals.
This genotype is rare in the general population.
Confirmed NF1 variant carrier
This genotype indicates the presence of two copies of the G allele, which is classified as pathogenic. This variant is associated with neurofibromatosis type 1 and an increased risk for developing certain malignancies, such as malignant nerve sheath tumors or other neurofibromas. Please consult with a genetic counselor or medical specialist to discuss these findings and appropriate clinical monitoring.
This genotype is extremely rare in the general population.
What is the rs1057518904 Variant?
The rs1057518904 variant is a specific change in the DNA sequence of the NF1 gene. In genomics, a variant like this represents a deviation from the most common sequence found in the human population. This particular variant is located on chromosome 17, which houses the NF1 gene. Because the NF1 gene is quite large, spanning over 280,000 base pairs, the exact location of a variant is critical for understanding how it might disrupt the gene's function. When a variant is classified as pathogenic, it means that scientific evidence suggests this change can interfere with the normal biological processes governed by the gene. Researchers identify these variants through advanced sequencing technologies, which allow them to pinpoint the exact location of the change and compare it against reference genomes to determine its potential impact on human health.
The Role of the NF1 Gene
The NF1 gene provides instructions for producing a protein called neurofibromin. This protein acts as a tumor suppressor, which is a vital role in maintaining healthy cell growth. Neurofibromin functions primarily as a negative regulator of the RAS signaling pathway, a system that tells cells when to grow and divide. When neurofibromin is working correctly, it keeps this pathway in check, preventing cells from multiplying uncontrollably. If the NF1 gene is altered by a pathogenic variant, the resulting neurofibromin protein may be truncated, unstable, or entirely absent. Without sufficient functional neurofibromin, the RAS pathway can become overactive, potentially leading to the development of tumors. This is why pathogenic variants in NF1 are linked to tumor predisposition syndromes, where individuals may have a higher-than-average risk of developing various types of growths throughout their lives.
Research and Clinical Associations
Scientific research has established a strong link between pathogenic variants in the NF1 gene and neurofibromatosis type 1 (NF1). This is an autosomal dominant disorder, meaning that a single copy of a pathogenic variant is sufficient to increase the risk of the condition. Clinical features of NF1 are diverse and can include dermatological signs like café-au-lait macules, as well as neurological and skeletal manifestations. While the evidence for the pathogenicity of specific variants is often derived from clinical case studies and molecular analysis, it is important to note that the clinical expression of these variants can be highly variable even among family members. Researchers continue to study how these variants influence the severity of the condition, looking for 'genetic modifiers' that might explain why some individuals experience more severe symptoms than others. Genetic testing for NF1 is typically reserved for cases where a clinical diagnosis is unclear or for research purposes.
What You Can and Cannot Do With This Information
If you have received information about an NF1 variant, it is essential to understand the limitations of this data. Genetic information is complex and should never be used to self-diagnose or make medical decisions without professional guidance. If you are concerned about your genetic risk, the most appropriate step is to consult with a board-certified genetic counselor or a medical geneticist. These professionals can help interpret your results in the context of your personal and family medical history. They can also explain the implications of the variant, discuss the necessity of clinical screening, and provide support for your specific situation. Remember that having a genetic variant does not guarantee the development of a condition, and many factors, including other genes and environmental influences, play a role in health outcomes. Always discuss any findings from genetic reports with your primary care physician or a specialist.
How common is this variant?
The rs1057518904 variant is considered rare in the general population. It is not a common polymorphism and is typically identified in clinical settings during the investigation of neurofibromatosis.
Frequently asked questions
What is neurofibromatosis type 1?
Neurofibromatosis type 1 is a genetic disorder that causes tumors to form on nerve tissue. It is caused by pathogenic variants in the NF1 gene and can affect many parts of the body, including the skin, bones, and nervous system.
Is this variant inherited or spontaneous?
Pathogenic variants in the NF1 gene can be inherited from a parent or occur as a de novo (new) mutation in an individual. Genetic testing and family history analysis are required to determine the origin of the variant.
Does having this variant mean I will get cancer?
Not necessarily. While this variant is associated with an increased risk of tumor development, it does not mean that a diagnosis of cancer is inevitable. Clinical management focuses on regular monitoring and early detection.
Where can I get tested for NF1 variants?
Genetic testing for NF1 is typically ordered by a healthcare provider, such as a geneticist or neurologist, when there is a clinical suspicion of the condition. You should discuss the appropriateness of testing with your doctor.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057518904?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29